Kai-Keen Shiu, Consultant Medical Oncologist at University College London Hospitals NHS Foundation Trust, shared on LinkedIn:
“I look forward to welcoming as many friends and colleagues – old and new – to APGCS 2026 in Singapore next week.
Central to, and a true benefit of, this meeting are the lively debates and MDT sessions we have throughout, bringing the latest trial results to the forefront of our minds at our own MDTs/Tumour Boards, clinics, and ward rounds ‘on Monday morning’.
I am especially looking forward to this Neoadjuvant Immunotherapy in dMMR CRC debate I will have with Cathy Eng, moderated by my Scientific Faculty and CRC Co-Chair Evelyn Yi Ting Wong. I’m prepared to be challenged by Cathy and the audience!”
Quoting Asia-Pacific Gastroenterology Cancer Summit:
“A Debate That Could Change Practice: Neoadjuvant Immunotherapy in dMMR CRC
Will neoadjuvant immunotherapy become the standard of care for dMMR stage II/III colorectal cancer? Join us at APGCS 2026 for a high-level clinical debate that could reshape future treatment protocols.
Date: Saturday, 01 August 2026 09:50 – 10:20 HRS (SGT)
Location: Academia, Singapore
Secure your pass to challenge your perspective on CRC care.
- Register here“
Other articles from Kai-Keen Shiu and Asia-Pacific Gastroenterology Cancer Summit.